Cited by 67Autism Spectrum Disorder ResearchTryptophan and brain disordersMaternal Mental Health During Pregnancy and Postpartum

Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study

Open access
Zerbo, O, Traglia, M, Yoshida, C, Heuer, L S, Ashwood, P, Delorenze, G N, Hansen, R L, Kharrazi, M +4 more·2016·Translational Psychiatry

Abstract

Maternal pregnancy levels of the inflammatory marker C-reactive protein (CRP) has been previously associated with autism spectrum disorder (ASD) in the offspring. We conducted a population-based nested case–control study with 500 children with ASD, 235 with developmental delay (DD) and 580 general population (GP) controls to further investigate whether elevated CRP during pregnancy increases the risk of ASD. Maternal CRP concentration was measured in archived serum collected during 15–19 weeks of pregnancy and genome-wide single-nucleotide polymorphism (SNP) data were generated. The levels of CRP were compared between ASD vs GP and DD vs GP. The genetic associations with CRP were assessed via linear regression. Maternal CRP levels in mid-pregnancy were lower in mothers of ASD compared with controls. The maternal CRP levels in the upper third and fourth quartiles were associated with a 45 and 44% decreased risk of ASD, respectively. Two SNPs at the CRP locus showed strong association with CRP levels but they were not associated with ASD. No difference was found between maternal CRP levels of DD and controls. The reasons for the lower levels of CRP in mothers of ASD are not known with certainty but may be related to alterations in the immune response to infectious agents. The biological mechanisms underlying this association remain to be clarified.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/tp.2016.46

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Zerbo et al. found maternal blood C-reactive protein levels lower in weeks 15-19 of pregnancies of a child with ASD than in the general population, and the results appeared not to be genetic.

    “A 2016 study found maternal blood C-reactive protein levels to be lower in weeks 15-19 of pregnancies of a child with ASD than the general population, and although the results appear not to be genetic”

    From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as Zerbo et al, 2016

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zerbo, O., Traglia, M., Yoshida, C., Heuer, L. S., Ashwood, P., Delorenze, G. N., Hansen, R. L., Kharrazi, M., Van de Water, J., Yolken, R. H., Weiss, L. A., & Croen, L. A.
Affiliations
  • Kaiser Permanente (US)
  • University of California, San Francisco (US)
  • University of California, Davis (US)
  • California Department of Public Health (US)
  • Johns Hopkins University (US)
Corresponding author
Zerbo, O
Venue
Translational Psychiatry
Published
2016-04-19
Volume
6
Issue
4
Pages
e783-e783
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2338014412
Cited by
67
References
46
Citations by year
2026: 4 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 5 · 2020: 12 · 2019: 9 · 2018: 11 · 2017: 2 · 2016: 3
FWCI
5.30
Type
journal article
Language
en
Open access
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Institute of Environmental Health Sciences (R01ES016669)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Keywords
C-reactive protein, autism spectrum disorder, maternal inflammation, second trimester, developmental delay, genetic association, single nucleotide polymorphisms, maternal immune response, infectious agents, offspring risk
MeSH terms
Autism Spectrum Disorder, Adult, C-Reactive Protein, California, Female, Humans, Infant, Male, Mothers, Pregnancy, Pregnancy Trimester, Second, Risk, Case-Control Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review